With his original stats/findings you have to concerned about
the biology of the disease. In case you didn't know or realize PSA is not the only marker to follow the disease and could even be highly misleading, some forms of PCa get so aggressive they don't give off normal looking psa levels, and so an oncologist would be monitoring many things in blood work and urine, etc. Alkaline phostaphase level should be followed, a urine test like UnTx (Pyrilinks-D) or other can test for bone mets break down (thus red flag), there are others to check too. Zoladex and LHRH type drugs can give patients a list of possible side effects.
CTC test might reveal amount of circulating tumor cells and can be used to monitor progressions, a blood test thing, maybe $600-900 range. PCa can invade lungs and is somewhat common, like 17% of (mets) patients or such, the good news is it doesn't seem to thrive there (rare if it does), could effect breathing volume perhaps???? You want more tests, psa alone is not enough.
I am going to guess that if you get a proper panel markers testings, you will have some things way out of normal limits, which is somewhat telling information.
Post Edited (zufus) : 5/23/2013 3:02:28 PM (GMT-6)